<DOC>
	<DOCNO>NCT00140998</DOCNO>
	<brief_summary>The study attempt evaluate way administer estrogen , principal female hormone , via patch orally , affect way estrogen work girl Turner Syndrome . These girl short whose ovary work . We examine change bone , protein fat metabolism influence estrogen deliver patch trough skin v estrogen take orally . These study conduct girl take GH therapy .</brief_summary>
	<brief_title>Estrogen Treatment ( Oral vs. Patches ) Turner Syndrome</brief_title>
	<detailed_description>Girls Turner Syndrome , age 10-16 year , choose study population . The study require 3 overnight admission in-patient Clinical Research Center ( CRC ) . A baseline study perform use stable isotope tracer leucine , glycerol glucose serial blood sample measure protein fat metabolism . Indirect calorimetry use measure substrate oxidation rate total energy expenditure . DEXA scan use measure bone mineral density body composition . Once baseline study complete subject randomly assign receive either estrogen orally patch place onto skin increase dos change every 2 week . After 6 week estrogen treatment second metabolic study , identical first , perform , follow wash period 4 week . Subsequently , subject switch alternate form estrogen . At end 6 week third final metabolic study repeat . All subject continue growth hormone throughout study procedure .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Menopause , Premature</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Girls Turner syndrome 1016 year old receiving growth hormone treatment . Systemic disease concomitant treatment wtih Oxandrolone . Significant obesity chronic steroid use .</criteria>
	<gender>Female</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Turner syndrome</keyword>
	<keyword>Hypogonadism</keyword>
	<keyword>GH</keyword>
	<keyword>Estrogen</keyword>
	<keyword>Estrogen Patches</keyword>
	<keyword>IGF-I</keyword>
	<keyword>Body Composition</keyword>
	<keyword>Protein Metabolism</keyword>
	<keyword>Lipolysis</keyword>
</DOC>